The two steel companies list “a golden share to be issued to the U.S. government” among the aspects of what they call a ...

Sarepta Therapeutics shares plunged 36% after the company reported a second case of acute liver failure resulting in death from taking Elevidys, which is a gene therapy for patients with Duchenne ...

Sarepta Therapeutics falls sharply after suspending shipments of Elevidys for infusions in non-ambulatory patients because of ...

Shares in US Steel (X) were up 5% in pre-market trading on Monday, after president Donald Trump signed an executive order on ...